The market of artificial blood vessels is estimated to be $2.1 billion in 2022 and is forecasted to grow at a CAGR of 5.3% to reach a value of $2.8 billion by 2028.
Specific rankings of companies in the global market for artificial blood vessels: might have changed. However, here are five companies that were prominent players in this field, along with brief descriptions of their contributions:
Artivion,Inc: is a medical technology company dedicated to advancing vascular health through innovative solutions. Specializing in the artificial blood vessels sector, focuses on cutting-edge research and development to provide state-of-the-art medical interventions for cardiovascular care.
Braun SE: is a global healthcare company with a significant presence in the artificial blood vessels market. Renowned for its expertise in medical solutions, it is a key player in developing and delivering advanced technologies, including those related to vascular health.
Becton, Dickinson, and Company: is a major player in the medical technology industry, contributing significantly to the artificial blood vessels market. Known for its commitment to healthcare innovation, the company specializes in a broad range of medical devices and solutions, including those related to vascular health.
Getinge: is a global medical technology company that plays a crucial role in the artificial blood vessels market. With a focus on precision and reliability, develops and delivers a diverse range of healthcare solutions, contributing to advancements in vascular care and medical interventions.
Humacyte : is a pioneering company in the field of regenerative medicine, specializing in bioengineered blood vessels. Focused on addressing critical medical need.
Each of the mentioned companies in the Global Market for Artificial Blood Vessels contributes uniquely to the field of vascular health through various products, technologies, and innovations.
The Global Market for Artificial Blood Vessels is positioned for significant growth with a projected CAGR of 5.3% from 2023 to 2028, reaching a forecasted size of $2.8 billion. The introduction highlights the market's importance in addressing cardiovascular diseases and the role of artificial blood vessels in reshaping healthcare. Key drivers, including the prevalence of cardiovascular diseases, strategic initiatives, and contributions from key companies like ARTIVION INC., B. BRAUN SE, and HUMACYTE, underscore the market's dynamic potential. With these factors at play, the market is poised to advance cardiovascular care, offering innovative solutions for the global healthcare landscape.
Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.
Contact us today to find out more.
We are your trusted research partner, providing actionable insights and custom consulting across life sciences, advanced materials, and technology. Allow BCC Research to nurture your smartest business decisions today, tomorrow, and beyond.Contact Us